The board of directors of Bristol-Myers Squibb Company (NYSE:BMY), a biopharmaceutical company, declared a quarterly dividend of USD0.45 per share on the company's USD0.10 par value common stock, it disclosed on Tuesday.

This next quarterly common stock dividend is due on 1 May 2020 to stockholders of record at the close of business as of 3 April 2020.

Additionally, the board declared a quarterly dividend of USD0.50 per share on Bristol-Myers Squibb's USD2.00 convertible preferred stock.

Stockholders of record at the close of business as of 5 May 2020 will receive the preferred stock dividend on 1 June 2020 to